Corteva, Inc. Profile Avatar - Palmy Investing

Corteva, Inc.

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms.
Agricultural Inputs
US, Indianapolis [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 0% Bad
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -47.50 40.44 77.02
Graham Fair Price 28.65 21.82 16.96
PEG -94.58 -0.09 1.67
Price/Book 21.06 1.63 1.35
Price/Cash Flow 82.47 -14.65 8.03
Prices/Earnings -27.69 24.10 -33.34
Price/Sales -1.18 8.99 9.10
Price/FCF 82.47 -14.65 8.03
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 12.31 0.41 0.36
Operating Margin 403.80 0.17 0.03
ROA 63.22 < 0.005 < 0.005
ROE -0.01 0.02 67.42
ROIC < 0.005 0.02 523.32
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.86 -0.58 49.50
Dividends QOQ -1.00 0.00 inf
EBIT QOQ 1.39 5.10 266.29
EPS QOQ 0.20 2.67 1233.33
FCF QOQ 16.73 -1.66 -90.10
Revenue QOQ 0.43 0.21 -50.90
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 262.43 208.65 -20.49
Days Sales Outstanding (DSO) 133.24 158.96 19.31
Inventory Turnover 0.34 0.43 25.78
Debt/Capitalization 0.09 0.16 74.46
Quick Ratio 0.79 0.89 12.74
Naive Interpretation member
04 - Leverage & Liquidity · Bad
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 35.56 35.36 -0.57
Cash 3.89 3.09 -20.56
Capex -0.26 -0.21 18.71
Free Cash Flow 5.97 -3.94 -34.04
Revenue 5.27 6.41 21.80
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.56 1.51 -3.04
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -0.36 2.47 594.24
Naive Interpretation Member
06 - Financial Health · Weak
End of CTVA's Analysis
CIK: 1755672 CUSIP: 22052L104 ISIN: US22052L1044 LEI: - UEI: -
Secondary Listings
CTVA has no secondary listings inside our databases.